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Neural-fate stabilizationascent neural ectoderm concomitant with several other neural-fate specifying
transcription factors. We used loss-of-function and gain-of-function approaches to analyze the functional
position of foxD5 amongst these other factors. Loss of FoxD5 reduces the expression of sox2, sox11, soxD, zic1,
zic3 and Xiro1–3 at the onset of gastrulation, and of geminin, sox3 and zic2, which are maternally expressed,
by late gastrulation. At neural plate stages most of these genes remain reduced, but the domains of zic1 and
zic3 are expanded. Increased FoxD5 induces geminin and zic2, weakly represses sox11 at early gastrula but
later (st12) induces it; weakly represses sox2 and sox3 transiently and strongly represses soxD, zic1, zic3 and
Xiro1–3. The foxD5 effects on zic1, zic3 and Xiro1–3 involve transcriptional repression, whereas those on
geminin and zic2 involve transcriptional activation. foxD5's effects on geminin, sox11 and zic2 occur at the
onset of gastrulation, whereas the other genes require earlier foxD5 activity. geminin, sox11 and zic2, each of
which is up-regulated directly by foxD5, are all required to account for foxD5 phenotypes, indicating that this
triad constitutes a transcriptional network rather than linear path that coordinately up-regulates genes that
promote an immature neural fate and inhibits genes that promote the onset of neural differentiation. We also
show that foxD5 promotes an ectopic neural fate in the epidermis by reducing BMP signaling. Several of the
genes that are repressed by foxD5 in turn reduce foxD5 expression, contributing to the medial–lateral
patterning of the neural plate.
© 2009 Elsevier Inc. All rights reserved.IntroductionThe neural ectoderm (NE) forms on the dorsal side of the
vertebrate embryo in response to factors secreted from the dorsal
blastula center (BCNE) and the Organizer that inhibit BMP signaling
(De Robertis and Kuroda, 2004; Kuroda et al., 2004; Levine and
Brivanlou, 2007). As a result, several transcription factors (TFs) are co-
expressed in broad overlapping domains in the nascent NE (Fig. 1A).
The mRNAs of several (geminin [gem], sox3, sox11, soxD) are detected
throughout the dorsal ectoderm at the onset of gastrulation; soxD also
is expressed in the ventral ectoderm until about stage 12. The
transcripts of others (foxD5, sox2, zic1, zic2, zic3) are concentrated in a
broad band near the blastoporal lip, although faint expression also
extends through the gem/sox domain. The transcripts of a third group
(Xiro1, Xiro2, Xiro3) are detected in two dorso-lateral bands near the
blastoporal lip. Although a few of these NE genes are expressed
maternally, most are expressed around the onset of gastrulation and
continue to be expressed through neural tube stages (Fig. 1C). As the
neural plate begins to form at the end of gastrulation, the expression
domains of these genes begin to be conﬁned to distinct domains,l rights reserved.presaging their roles in regional identity and neural differentiation
(Fig. 1B). foxD5 is strongly expressed along the midline and central
region of the anterior neural plate. The sox genes are broadly
expressed throughout the neural plate except in the regions expres-
sing high levels of foxD5. gem is expressed similar to the sox genes, but
more intensely in the anterior rather than posterior neural plate. The
zic genes are expressed in the lateral regions of the neural plate, and
the Xiro genes are expressed anteriorly in a lateral bar, and posteriorly
in a longitudinal band lateral to the midline. Experiments in Xenopus
demonstrated that most of these TFs are induced by reducing BMP
signaling, and they all expand the neural plate when their expression
levels in dorsal ectoderm are increased by mRNA injection (reviewed
in Sasai, 1998; Moody and Je, 2002). In addition, some maintain an
immature neural state while others promote the expression of bHLH
neural differentiation genes. However, there are very few studies that
describe how these genes interact to maintain NE cells as neurogenic,
establish the neural plate and initiate neural differentiation. Under-
standing how these TFs relate to each other is fundamental for
understanding the molecular regulation of the progression from the
initially-induced NE to a patterned neural plate and then to neural
progenitor cells poised to begin their various differentiation programs.
A number of NE genes appear to repress or delay the initiation of
neural differentiation. For example, gem and zic2 repress neural
differentiation genes and can counteract the formation of ectopic
Fig. 1. Twelve neural ectodermal genes have overlapping expression patterns during the establishment of the neural plate. (A) At the onset of gastrulation (st10), some NE genes are
expressed throughout the dorsal ectoderm (yellow: gem, sox3, sox11, soxD), some are expressed only in a broad dorsal band adjacent to the blastopore lip (bl) (blue: foxD5, sox2,
zic1–3), and the Xiro genes (green) are expressed weakly in two posterior-lateral bands. Dorsal view with animal pole (AP) to the bottom. (B) When the neural plate is established
(∼st 14), the domains of these genes segregate. Although not illustrated, the domains of gem and sox genes overlap with both the zic and Xiro genes. Dorsal view with anterior to the
bottom. (C) The temporal patterns of expression also overlap extensively. Four genes (foxD5, gem, sox3, zic2) are expressed maternally with detectable mRNAs through blastula
stages; sox11 is expressed in oocytes but is not detected at blastula stages. The zygotic expression of most of these genes begins at late blastula (st9) to early gastrula (st10). The
expression of nearly all is maintained through neural tube (nt) stages; in contrast, foxD5 is lost as the neural plate is established (st14). See references in text for original descriptions
of expression patterns.
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Kroll et al., 1998). foxD5 expands a marker of immature NE (otx2)
and represses neural differentiation genes (Sullivan et al., 2001). In
several animals, sox2 and sox3 are expressed throughout neural
stem populations and must be down-regulated for neural progenitor
differentiation (Mizuseki et al., 1998a; Kishi et al., 2000; Bylund
et al., 2003; Graham et al., 2003). There are few studies of sox11, but
it appears to function in neural stem cells, their transition to neural
progenitor cells, and in neuronal progenitors downstream of
proneural genes (Uwanogho et al., 1995; Wegner and Stolt, 2005).
Other NE genes promote the onset of neural differentiation.
Although zic1 is required early for neural competence (Kuo et al.,
1998), it also is required for the expression of soxD (a member of
the Sox G group; Wegner, 1999), which causes ectopic neural
masses that express neural differentiation genes (Mizuseki et al.,
1998b); zic3 also induces neural differentiation genes (Nakata et al.,
1997). In Drosophila, Iroquois genes are required for the activation of
proneural bHLH genes (Gomez-Skarmeta et al., 1996), and in Xe-
nopus, Xiro genes are expressed just prior to the earliest expressed
bHLH neural differentiation genes, promote the onset of neural
differentiation (Bellefroid et al., 1998; Gómez-Skarmeta et al., 1998),
but suppress terminal differentiation into neurons (De la Calle-
Mustienes et al., 2002).
It seems likely that together these NE genes coordinately
regulate expansion of the NE, formation/patterning of the neural
plate, and the onset of neural differentiation. However, our under-
standing of the functional and transcriptional relationships between
them is woefully incomplete. Are the genes in each group and/or in
each TF family simply redundant or do they have distinct roles in
the transition from neural induction to the onset of neural
differentiation? As a ﬁrst step in answering these questions we
analyzed the functional position of foxD5 amongst these 11 other
TFs by: 1) reducing endogenous FoxD5 levels in the NE by targeted
injection of antisense morpholino oligonucleotides directed against
foxD5 (foxD5-MOs); 2) elevating foxD5 expression via mRNA
injection into 16-cell blastomeres that give rise to either the NE or
ventral epidermis; 3) testing the timing of the foxD5 effects on the
TFs with a hormone-inducible construct; and 4) elevating the
expression of the 11 other TFs by mRNA injection to test whether
they alter foxD5 expression. These experiments indicate that foxD5
regulates each TF and a few of them feedback to down-regulate
foxD5, contributing to the medial–lateral patterning of the neural
plate. Furthermore, we demonstrate that foxD5 regulates these
genes by both transcriptional activation and transcriptional repres-
sion. We provide evidence that gem, sox11 and zic2 are direct
transcriptional targets of FoxD5, and that together they account for
most of the effects of foxD5 on the remaining TFs. These
experiments reveal that several NE genes coordinately expand the
NE during gastrulation, specify neural plate formation and pattern-
ing, and regulate the initiation of neural differentiation. foxD5 is a
critical upstream component of this transcriptional network and it
functions via a transcriptional triad, consisting of gem, sox11 and
zic2, to induce/expand those NE genes that maintain an immature,
neurally-committed state, and inhibit those NE genes that promote
bHLH neural differentiation genes.Fig. 2. FoxD5 is required for the normal expression of NE genes. (A) Myc-tagged FoxD5 (
expression is greatly reduced in the presence of foxD5-MOs (foxMOs). Myc-tagged N-termin
Control MO (cMO) does not alter the expression of sox2 on the injected side (⁎) of the embry
foxMOs reduction of sox2 expression (cf. E) on the injected side (⁎) of the embryo (st15, sam
(reduced expression above x-axis; expanded expression below x-axis) after injection of fo
ΔNfoxD5 mRNA (analyzed at st14). These data indicate that the effects of foxD5-MOs are s
indicated above each bar. (E) Arrows denote patches of reduced gene expression at the site
(st13–15) stages. For zic1 and zic3, foxD5-MOs expand their expression domains at neural
zic3, Xiro1 and Xiro2: dorsal views with anterior to the bottom; for sox3, anterior view with
and neural plate stages are anterior views (as for sox3); for Xiro3: st10.5 is vegetal view wMaterials and methods
mRNA injections
Fertilized Xenopus laevis eggs were obtained by gonadotropin-
induced natural mating of adult frogs (Moody, 2000). mRNAs were
synthesized in vitro and injected at the indicated concentrations:
foxD5 (150 pg, Sullivan et al., 2001), n-geminin (N-terminal neuraliz-
ing domain, 20 pg, Kroll et al., 1998), sox2 (200 pg, Mizuseki et al.,
1998a), sox3 (200 pg, Penzel et al., 1997), sox11 (200 pg, Hiraoka et al.,
1997), soxD (200 pg, Mizuseki et al., 1998b), Xiro1 (200 pg, Gomez-
Skarmeta et al., 2001), Xiro2 (200 pg, Gómez-Skarmeta et al., 1998),
Xiro3 (200 pg, Bellefroid et al., 1998), zic1 (200 pg, Mizuseki et al.,
1998a), zic2 (100 pg, Brewster et al., 1998), zic3 (100 pg, Nakata et al.,
1997), foxD5VP16 (100 pg; Sullivan et al., 2001) and EnRfoxD5
(100 pg; Sullivan et al., 2001). Test mRNAs were mixed with lineage
tracer mRNA (nuclear and cytoplasmicβ-gal, 100 pg) and injected into
one blastomere of the 16-cell embryo (Moody, 2000). Transcripts
were injected into either a dorsal animal blastomere (D1.1) to target
expression to the NE or a ventral animal blastomere (V1.1) to target
expression to the ventral epidermis (Moody, 1987).
FoxD5 hormone-inducible construct
To generate a hormone-inducible foxD5 vector, the ligand-binding
domain of the human glucocorticoid receptor (hGR) plus the myc-tag
(MT) were released by digesting pCS2+-hGRMT (Hutcheson and
Vetter, 2001) with BamHI and NcoI. This fragment was inserted into
the BamHI/NcoI site upstream of the Xenopus foxD5 open reading
frame replacing the MT in the pCS2+MT-foxD5 plasmid (Sullivan et
al., 2001). The pCS2+-hGRMT-foxD5 plasmid was conﬁrmed by
sequencing and used as template to generate mRNA (foxD5-hGR).
After mRNA injection, cells synthesize the fusion protein, but the hGR
domain forms a complex with endogenous heat shock proteins that
prevents the transcription factor from entering the nucleus (Mattioni
et al., 1994; Kolm and Sive, 1995). To uncouple this complex and allow
nuclear translocation, control and injected embryos were incubated in
synthetic hormone (10 μM dexamethasone, Dex) according to
published protocols (Kolm and Sive, 1995). To ensure that the
foxD5-hGR construct functioned as expected, some injected embryos
were treated with hormone immediately after mRNA injection (+Dex
cleavage; see Fig. 5); these embryos phenocopied those injected with
wild-type (wt) foxD5 mRNA (Sullivan et al., 2001). For the experi-
ments reported herein, embryos were treated with hormone starting
at several different time points prior to and during gastrulation;
hormone was maintained in the medium throughout the culture
period. Experiments in tissue culture and in whole embryos with
similar hGR-fusion constructs indicate that robust protein activation
occurs within 90 min after hormone treatment, and is maintained for
several days (Hollenberg et al., 1993; Mattioni et al., 1994; Kolm and
Sive,1995; de Graaf et al., 1998). Therefore, we assume that the FoxD5-
hGR protein was available to affect downstream targets throughout
the culture period of our experiments. Embryos were ﬁxed and
analyzed at stages (st) 14/15 (for the 11 NE genes) or st19/20 (for
ngnr1, neuroD) when cultured without Dex, or treated with Dex atfoxD5-MT) is highly expressed in both the cytoplasm and nucleus (arrowheads); this
al deleted FoxD5 (ΔN-foxD5) is strongly expressed even in the presence of foxMOs. (B)
o (st14, dorsal view, anterior is down). (C) Co-injection of ΔNfoxD5mRNA prevents the
e view as in B). (D) The percentage of embryos exhibiting the phenotypes shown in E
xD5-MOs (analyzed at four different stages), cMO (analyzed at st14) or foxD5-MOs+
peciﬁc and can be rescued in a high percentage of cases by ΔNfoxD5. Sample sizes are
of foxD5-MOs injection for each NE gene at gastrulation (st10.5–12) and neural plate
plate stages (lines denote width of neural plate on injected sides). For gem, sox2, zic2,
dorsal to the top; for sox11, soxD, and zic1: gastrula stages are dorsal views (as for gem)
ith dorsal to the top and st13 is dorsal view (as for Xiro1, 2).
83B. Yan et al. / Developmental Biology 329 (2009) 80–95cleavage or st7–9. Embryos were ﬁxed and analyzed at st15/16 (for
sox2, sox3, soxD, Xiro1–3) or st19/20 (for ngnr1, neuroD) when treated
with Dex at st11–13. Some embryos were injected with foxD5-hGR
mRNA and raised in the absence of hormone (w/o Dex; see Fig. 5);
expression patterns of the other NE genes were altered in fewer than
10% of embryos indicating that the hormone-inducible construct haslittle effect in the absence of hormone, in accord with published
accounts (Hollenberg et al., 1993; Mattioni et al., 1994; Kolm and Sive,
1995; de Graaf et al., 1998). In addition, uninjected control embryos
were treated with Dex at cleavage stages; expression patterns of the
other NE genes were identical to untreated embryos indicating that
Dex treatment alone does not affect NE gene expression. To block
Table 1
The effects of altering FoxD5 levels on the cell-autonomous expression of neural
ectodermal (NE) transcription factors
NE gene FoxD5 LOF FoxD5 GOF
Gastrula Neural plate Gastrula Neural plate
gem −, st12 − + +
sox2 − − −, w nc
sox3 −, st12 − −, w nc
sox11 − − −, w +
soxD − − nc −
zic1 − + − −
zic2 −, st12 − + +
zic3 − + − −
Xiro1 − − − −
Xiro2 − − − −
Xiro3 − − − −
LOF, loss-of-function by injecting foxD5-MOs; GOF, gain-of-function by injecting foxD5
mRNA; −, reduced gene expression; +, increased gene expression; nc, no change in
gene expression; w, weak effect; st12, stage at which the foxD5-MOs-mediated
reduction was ﬁrst observed for gem, sox3 and zic2. Gastrula includes stages 10–12.5;
neural plate includes stages 13–15.
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foxD5-hGR, then at st8.5 they were incubated in cycloheximide (Chx,
10 μg/ml; Kurth et al., 2005). After 30–40 min the Chx medium was
supplemented with Dex and embryos allowed to develop until
siblings reached st12.
Morpholino antisense oligonucleotides
Two morpholino antisense oligonucleotides (MOs) were synthe-
sized to recognize the translational start site of all three foxD5
paralogues found in X. laevis (5′-CAGACTCCTGGCTAAAGCTCATTGT-3′;
5′-TATACTCTGATGCTGGGTTTGTAGC-3′) (Gene Tools, LLC). An equi-
molar mixture of the two foxD5-MOs, or a standard control MO (cMO;
Gene Tools, LLC) was microinjected (16 ng) into blastomere D1.1, a
major progenitor of the NE (Moody, 1987). A myc-tagged construct
(foxD5-MT) containing the foxD5 wt 5′UTR was generated to assess
foxD5-MO knock-down efﬁcacy by immunohistochemical detection
of the fusion protein. A myc-tagged, N-terminally truncated foxD5
mRNA (ΔNfoxD5), which has full FoxD5 function (Sullivan et al., 2001)
but does not contain the appropriate 5′ sequence to bind the foxD5-
MOs, was used to demonstrate that the effects of foxD5-MOs could be
rescued speciﬁcally by exogenous FoxD5. The mRNAs for foxD5-MT
and ΔNfoxD5, with or without foxD5-MOs, were injected, embryos
ﬁxed at gastrulation (st10.5–12), sectioned with a cryostat and
processed for immunoﬂuorescence as previously reported (Huang
andMoody,1995), usingmouse anti-c-myc (Sigma; 1:1000) and Alexa
Fluor 488 goat anti-mouse IgG (Invitrogen; 1:200) antibodies.
Sections were viewed with epiﬂuorescence and digital images
collected using the identical exposure times.
Whole mount in situ hybridization and immunocytochemistry
For whole mount in situ hybridization, embryos were ﬁxed,
stained for expression of the nuclear βGal lineage tracer andFig. 3. foxD5 mRNA injected into D1.1 lineages affects all 11 NE genes. (A) foxD5-expressing
neural plate (right) stages. For gastrula, small arrow denotes blastopore lip and inset shows
sox3 (C) wereweakly reduced (small arrows) compared to adjacent NE cells (⁎) at gastrula st
when their expression domains were expanded on the injected side (black lines); anterior vi
(small arrows) compared to adjacent NE cells (⁎) at early gastrula (dorsal viewwith anterior t
plate (above white arrows) and in the adjacent ectoderm (red asterisk). Black bar indicates th
soxD expressionwas unaffected at early gastrulation (dorsal viewwith anterior to the bottom
stage 12 (bottom inset). The reduced phenotype was maintained at neural plate (anterior-la
(red nuclei) compared to adjacent NE cells (⁎). For zic2 (G), foxD5-expressing cells (dark bl
stages (arrow depicts ectopic expression along the midline). Both are dorsal views with ante
cells (red nuclei) compared to adjacent NE cells (⁎) at gastrulation. Gaps in their expression (
neural plate stages. Xiro1 (I), Xiro2 (J) and Xiro3 (K) were repressed (arrows) at both gastrul
and sample sizes are indicated. (L) These results were conﬁrmed for several of the NE geneprocessed using digoxigenin-labeled RNA probes for each of the
genes listed above (Sive et al., 2000). Embryos were analyzed for
whether the expression domain was expanded or decreased in size or
staining intensity, compared to the expression in control embryos and
to the uninjected side of the same embryo. For whole mount
immunostaining, foxD5-injected embryos were processed according
to Faure et al. (2000) using a rabbit anti-phosphoSMAD1/5/8
antiserum (1:100; Cell Signaling). Stained nuclei in the ventral
epidermis were counted within a 1 mm2 grid overlying foxD5-
expressing cells (identiﬁed by the blue cytoplasmic βGal lineage
tracer), cells on the uninjected side of the same embryo, and similarly
located cells in control, uninjected embryos. Cell counts from the same
embryos (injected versus uninjected sides) were compared by the
paired t-test; those from different embryos (injected sides versus
control uninjected embryos) were compared by the unpaired t-test.
Animal cap explants and PCR
Both cells of the 2-cell embryo were injected with foxD5 mRNA.
Animal cap explants (ACs) were cut at st8.5 and collected at st12–13.
Semiquantitative RT-PCR within linear ranges was performed as
previously described (Huang et al., 2007). All PCRs were repeated at
least 3 times. Some primers were obtained from previous publications
(H4: Niehrs et al., 1994; zic1, zic2, zic3: Kato et al., 1999), and others
were designed with MIT Primer3 software (Rozen and Skaletsky,
2000). The size of PCR product, cycle numbers and primer
sequences for the latter are: geminin (224 bp, 25), 5′-GGCAGGCAC-
CAGGTTTAATA-3′ (forward), 5′-TCAGCTGATCATTCCACAGC-3′
(reverse); sox2 (160 bp, 25), 5′-AGTCCACCTGTAGTCACCTCTTCTT-3′
(forward), 5′-GCTACTGAGGCACTCTGATAGTGTT-3′ (reverse); sox3
(162 bp, 25), 5′-CAAACAGGACTTTTTGTTTTGTTCT-3′ (forward), 5′-




foxD5 alters the expression of 11 TFs that are co-expressed in the NE
foxD5 and 11 other TFs are expressed at about the same time in the
nascent NE (Fig.1), suggesting that theymay coordinately regulate the
acquisition of neural fate, formation and patterning of the neural plate
and onset of neural differentiation. To determine the functional
position of foxD5 amongst these genes we ﬁrst tested whether foxD5
is required for their normal expression patterns by reducing
endogenous levels of FoxD5 with foxD5-MOs. These effectively
blocked translation of a myc-tagged full-length foxD5, but had no
detectable effect on amyc-tagged construct (ΔNfoxD5) inwhich the 5′
sequences recognized by the foxD5-MOs were deleted (Fig. 2A).
Embryos were analyzed by comparing the expression domains of NE
genes on MO-injected versus uninjected sides. For all NE genes,
injection of a control MO (cMO) rarely altered the NE gene domain in
the stage 14/15 neural plate on the injected side (Figs. 2B, D); nearly
all embryos were indistinguishable from uninjected control embryos.cells (red nuclei) showed increased expression of gem at both gastrulation (left) and
cells at a higher magniﬁcation. Dorsal views with anterior to the bottom. sox2 (B) and
ages (dorsal viewswith anterior to the bottom). This effect waned by neural plate stages,
ews with dorsal to the top. (D) foxD5-expressing cells showed reduced sox11 expression
o the bottom), but later (by st12) showed highly increased expression in both the neural
e expanded sox11 domain on the injected side. Anterior viewwith dorsal to the top. (E)
, and top inset), began to be reduced (small arrows) compared to adjacent NE cells (⁎) by
teral view) stages; higher magniﬁcation shows reduced soxD in foxD5-expressing cells
ue) showed increased expression at both gastrula (bracket and inset) and neural plate
rior to the bottom. zic1 (F) and zic3 (H) showed reduced expression in foxD5-expressing
large arrows) coinciding with foxD5-expressing cells (red nuclei) also were observed at
ation (not shown) and neural plate stages. For A–K, the percentage of embryos affected
s by RT-PCR comparing uninjected (Un) and foxD5-injected ACs. H4 is internal control.
85B. Yan et al. / Developmental Biology 329 (2009) 80–95Embryos that were co-injected with ΔNfoxD5 mRNA and foxD5-MOs
had normal expression domains on the injected side in the majority of
embryos (Figs. 2C, D). Together, these assays demonstrate that the
foxD5-MOs are both effective and speciﬁc in reducing FoxD5.
Injecting foxD5-MOs into a single 16-cell blastomere on one side of
the embryo caused a signiﬁcant reduction in the stage 14/15 neuralplate domains of gem, sox2, sox3, sox11, soxD, zic2, and Xiro1–3; in
contrast, the expression domains of zic1 and zic3 were expanded
(Table 1; Figs. 2D, E). To determine whether foxD5 is required for the
onset of the expression of the NE genes, similarly prepared embryos
were analyzed during gastrulation stages. Four different effects were
observed (Table 1; Figs. 2D, E). First, the NE domains of sox2, sox11 and
Fig. 4. foxD5 ectopically induces a subset of NE genes and represses the BMP pathway. (A) Left side: foxD5-expressing cells (arrows, red nuclei) express zic2 (blue cytoplasm) in the
st11 ventral epidermis, but do not express sox2; inset shows higher magniﬁcation of sox2 to demonstrate lack of blue cytoplasm surrounding red nuclei. Asterisks denote endogenous
gene expression on the dorsal sides of the embryos. Right side: high magniﬁcations show strong induction (⁎) of gem, zic2 and sox11 in the st11 ventral epidermis; the red nuclei are
partially masked by the blue signal in the cytoplasm. A few cells (arrows) weakly express sox3. (B) The percentage of embryos showing ectopic ventral induction of each NE gene
(collected at st10.5–13). Sample sizes are above each bar. (C) foxD5 expression in the ventral epidermis at gastrulation (st10–11) reduces the expression of two epidermal genes
downstream of BMP signaling. AP2 is expressed throughout the control ectoderm (left: animal view of whole embryo; right: higher magniﬁcation). foxD5-expressing cells (red
nuclei) show reduced AP2 expression. Asterisk denotes adjacent unaffected cells. Epidermis-speciﬁc keratin (epi-keratin) is expressed throughout the ventral ectoderm (left: ventral
view with animal hemisphere to the top of whole embryo; right: higher magniﬁcation). foxD5-expressing cells (red nuclei) show reduced epi-keratin expression. Asterisk denotes
adjacent unaffected cells. The frequencies of the phenotypes and sample sizes are given. (D) Injection of foxD5mRNA into a neural progenitor cell-autonomously induces szl (arrow)
in the neural plate (st13, anterior view). The frequency of the phenotype and sample size are given. (E) Injection of foxD5 mRNA cell-autonomously reduces the number of cells
displaying nuclear phospho-SMAD1/5/8 staining (brown nuclei) in the st11 ventral epidermis. Top panel illustrates staining in ventral epidermis of uninjected control embryo.
Bottom panel illustrates staining in a region of foxD5-expressing cells stained blue by expression of the cytoplasmic βGal lineage marker (asterisk) and in an adjacent region (right
side) that does not contain foxD5-expressing cells. Graph on right indicates the mean number of cells displaying nuclear phospho-SMAD1/5/8 staining in foxD5-expressing ventral
epidermis clones compared to the uninjected side (control) of the same embryos (n=16 per group). Bars indicate s.e.m. and ⁎ indicates pb0.0001 (paired t-test).
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of gastrulation (st10), indicating that FoxD5 is required for their initial
expression. Second, for those NE genes that are expressed maternally
(gem, sox3, zic2), very few embryos showed an effect until stage 12,
suggesting that either thematernalmRNA is intact at the earlier stages,
or that the onset of their zygotic expression does not require foxD5.
Third, zic1 and zic3 were initially reduced by foxD5-MOs, but at st12
this effect changed to an expansion of their domains. This result
suggests that foxD5 is required for their initial NE expression, but later
inhibits their neural plate expression. Fourth, the Xiro genes were
reduced starting at early gastrulation, but the frequency of affected
embryos gradually increased over developmental time. This result
suggests that foxD5 facilitates their initial expression, and is required
for their maintenance. Together, these results demonstrate that foxD5
is required for the normal expression patterns of all 11 NE genes, but it
has differential effects at different developmental times.
In accord with previous work (Sullivan et al., 2001), increasing
foxD5 levels by mRNA injection into a NE precursor blastomere
expanded the neural plate on the injected side, regardless of which NE
gene was examined (70.9% of embryos, n=457). Expansion was
observed in neural plate domains beyond the foxD5-expressing cells,
which were identiﬁed by a nuclear βgal lineage marker, indicating a
non-autonomous effect (see Figs. 3B–D as examples). In addition,Fig. 5. Timing of foxD5 effects on NE genes revealed by hormone-inducible foxD5 constru
mimicked wt foxD5 at equivalent frequencies for gem, sox11 and zic2 (cf. Figs. 3 and 6A). Very
phenotypes and no uninjected embryos treated with Dex (ctrl+Dex) showed the phenotyp
Dex treatment at progressively later stages caused the effects at lower frequencies. Controls
two neural differentiation genes (ngnr1, neuroD). Dex treatment at progressively later stages
these genes by the end of gastrulation (st13). Controls as in A. Sample sizes are above eachfoxD5-expressing cells showed several changes in the levels of their
expression of the other NE genes (Table 1; Fig. 3). These cells showed
markedly increased staining for gem and zic2 compared to adjacent
NE cells at both gastrulation and neural plate stages (Figs. 3A, G). The
sox genes were differentially affected. sox2 and sox3 were weakly
reduced in foxD5-expressing cells at gastrulation, but this effect
abated by neural plate stages (Figs. 3B, C). sox11 was weakly reduced
at early gastrulation (st10–11), but strongly induced in foxD5-
expressing cells from st12 through neural plate stages (Fig. 3D).
soxD was unaffected through mid-gastrulation (st11.5), after which it
was reduced (Fig. 3E). foxD5 reduced the expression of zic1 and zic3
from early gastrulation through neural plate stages (Figs. 3F, H); Xiro1,
Xiro2 and Xiro3 also were repressed at gastrulation (86%, n=36; 90%,
n=39; 88%, n=17, respectively) and neural plate (Figs. 3I–K) stages.
Because zic1, zic3, soxD and Xiro1–3 expression domains overlap with
that of foxD5 at early gastrulation (Fig. 1), the repression is likely due
to increasing FoxD5 protein above endogenous levels. The effects of
foxD5 on some of the NE genes were conﬁrmed by RT-PCR; foxD5-
expressing animal caps showed a signiﬁcant increase in expression
over controls for gem, sox11, sox2, sox3 and zic2 and a signiﬁcant
decrease in zic1 and zic3 (Fig. 3L). These data demonstrate that foxD5:
1) expands the neural plate; 2) up-regulates some NE genes; and 3)
down-regulates others. They also indicate that the expansion of thect. (A) foxD5-hGR induction by Dex treatment at either cleavage stage (32CS) or st9
few embryos injected with foxD5-hGR and cultured without Dex (w/o Dex) showed the
es. (B) Dex treatment at cleavage mimicked wt foxD5 effects on sox2, sox3, zic1 and zic3.
as in A. (C) Dex treatment at cleavage mimicked wt foxD5 effects on soxD, Xiro1–3 and
caused the effects at lower frequencies. The foxD5 effects were nearly abolished for all of
bar.
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regulation and down-regulation of the NE genes is either cell-
autonomous or mediated by very short-range signaling.
foxD5 reduces BMP signaling
To determine whether foxD5 could ectopically induce the expres-
sion of the other TFs, mRNA was injected into a blastomere precursor
of the ventral epidermis. gem, sox11 and zic2were ectopically induced
in a high percentage of embryos (Figs. 4A, B). A few embryos showed
weak ectopic expression of sox2, zic1 and Xiro2 and nearly half
showed weak ectopic sox3 expression. The remaining four NE genes
(soxD, zic3, Xiro1 and Xiro3) were not ectopically induced in any of the
embryos. Because a microarray analysis of potential downstream
targets of FoxD5 indicated that both bmp4 and bmp7 are repressed in
animal cap explants by foxD5 (Yan, Neilson and Moody, unpublished),
we tested whether the ventral ectopic induction of these NE genes
resulted from reduced BMP signaling. Two epidermal genes regulated
by BMP signaling (AP2 and epidermal keratin; Snape et al., 1991) were
strongly repressed by ventral expression of foxD5 (Fig. 4C). Further-
more, szl, a secreted antagonist of BMP signaling that is normally
expressed ventrally (Lee et al., 2006), is strongly induced in both the
NE and ventral epidermis (Fig. 4D). Finally, the numbers of cellsFig. 6. foxD5 regulates transcription by both activation and repression. (A) The percenta
expression after injection of wt foxD5, an activating construct (foxD5VP) or a repressing cons
st12 (soxD, Xiro1–3). Sample sizes for wt foxD5 are in Fig. 3, and for other constructs are
EnRfoxD5 induced only a few cells (arrows in both low and high magniﬁcation pictures). fo
the endogenous expression (⁎) along the lateral neural plate border, whereas EnRfoxD5 indu
EnRfoxD5 reduced zic1 expression in the st11 NE (arrow).containing nuclear phosphorylated SMAD1/5/8, which indicates
active BMP signaling (Faure et al., 2000), were signiﬁcantly reduced
in ventral epidermis expressing foxD5 compared to either adjacent
uninjected ventral epidermis in the same embryo or in control,
uninjected embryos (Fig. 4E). These data suggest that the non-cell-
autonomous expansion of the neural plate expression domains of the
11 NE genes is likely accomplished by foxD5 locally down-regulating
the BMP pathway. It remains to be determined whether this is
accomplished by directly down-regulating bmp gene transcription or
up-regulating the expression of secreted BMP antagonists such as Szl.
Timing of the foxD5 effects on NE genes
Endogenous foxD5 is present as both maternal and zygotic mRNAs
(Sölter et al., 1999; Fetka et al., 2000; Sullivan et al., 2001). Because the
above experiments provide foxD5 mRNA during cleavage stages, we
used a hormone-inducible foxD5 (foxD5-hGR) to determine the time
at which FoxD5 causes the above effects. Dex treatment of
uninjected embryos did not alter NE gene expression in the neural
plate (st14/15) nor did FoxD5-hGR have signiﬁcant activity in the
absence of Dex (Fig. 5). Adding Dex to the medium when foxD5-hGR
injected embryos reached 32–64 cells to activate protein as soon as it
is translated demonstrated that the hGR construct caused the samege of embryos showing either increased (above x-axis) or decreased (below x-axis)
truct (EnRfoxD5); embryos were collected at st10.5–11 (gem, sox2, sox3, sox11, zic1–3) or
above each bar. (B) foxD5VP strongly induced gem in st11 ventral epidermis, whereas
xD5VP induced zic2 expression in the st12 neural plate midline (bracket), distant from
ced only a few patches of cells (arrows in both low and high magniﬁcation pictures). (C)
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Fig. 3). The zygotic expression of foxD5 begins around st8–9 (Sullivan
et al., 2001), so we ﬁrst tested the effects of foxD5-hGR on neural plate
phenotypes by adding Dex to the culture just prior to the onset of
gastrulation (st9) and ﬁxing embryos at st14/15. gem, sox11 and zic2
were strongly induced in similar intensity and frequency as by wt
foxD5 (Fig. 5A). However, expansion of sox2 and sox3 domains and
reduction of zic1, zic3, soxD and Xiro1–3 domains occurred much less
frequently (Figs. 5B, C). These results indicate that the effects on
neural plate expression of gem, sox11 and zic2 are due to zygotic
FoxD5 activity at the onset of gastrulation, whereas the effects on the
other nine TFs require earlier FoxD5 activity. Culturing foxD5-hGR
embryos in Dex at ∼st7 (1 h after 16-cell blastomere injection) or ∼st8
(2 h after injection), however, did not signiﬁcantly increase the
frequencies of the phenotypes. This also was the case for ngnr1 and
neuroD (Fig. 5C), two bHLH neural differentiation factors up-regulated
by zic1, zic3, soxD and Xiro1–3. It must be kept in mind that it may
take up to 90 min after Dex treatment for the hGR-fusion protein to
access its DNA targets (Hollenberg et al., 1993; Mattioni et al., 1994;
Kolm and Sive, 1995; de Graaf et al., 1998). Thus, we cannot be certain
whether maternal or potential pre-MBT transcription (Yang et al.,
2002) of foxD5 account for the effects on these TFs. Nonetheless, these
data demonstrate that: 1) the effects on gem, sox11 and zic2
expression are mediated by zygotic FoxD5 by gastrula stages; 2) the
effects on gem, sox11 and zic2 do not depend on the other NE genes;
and 3) the effects on sox2, sox3, soxD, zic1, zic3 and Xiro1–3 partially
require FoxD5 activity at least by early blastula stages.
To determine the time after which foxD5 no longer affects the
genes involved in promoting neural differentiation, foxD5-hGR
embryos were cultured in Dex at gastrulation and ﬁxed at neurulation
(st16) or neural tube (st20) stages.When Dexwas added at st11 (mid-
gastrulation), the foxD5 effects on soxD, Xiro1 and Xiro2 wereFig. 7.When foxD5-hGRwas activated by Dex in the presence of Chx (+Chx/+Dex), the cells
not required. This induction did not occur in the absence of Dex (+Chx/−Dex) (arrows, red
their endogenous levels of gene expression (⁎, gem) or outside the normal endogenous dom
sizes are indicated below each example. Embryos were ﬁxed when siblings reached st12.abolished and those on Xiro3, ngnr1 and neuroDwere further reduced.
When Dexwas added at st13 (end of gastrulation) the foxD5 effects on
the latter three genes were nearly abolished. The time course over
which the foxD5 effects are abolished suggest that soxD, Xiro1 and
Xiro2 act upstream of Xiro3, ngnr1 and neuroD. Furthermore, this
time course coincideswith the down-regulation of foxD5 transcription
at neurulation (Fig. 1; Sullivan et al., 2001).
foxD5 regulates NE genes by both transcriptional activation and
repression
Different Forkhead TFs are known to regulate transcription by both
activation and repression of target genes (Carlsson and Mahlapuu,
2002; Wijcher et al., 2006). FoxD5 contains several regions (an acidic
“blob” in the N-terminal portion, and a P/A/Q-rich region, a “region II”
and a Groucho interaction motif in the C-terminal portion) that are
described in other Forkhead proteins to contribute to both transcrip-
tional activating and repressing activities (reviewed in Sullivan et al.,
2001; Yaklichkin et al., 2007). Previously we used constructs that
fused the DNA-binding domain to either the VP16 activating or the
EnR repressing domains to demonstrate that FoxD5 expansion of sox3
and otx2 and reduction of neural patterning (en2, Krox20) and
differentiation (ngnr1, neuroD) genes were mediated via transcrip-
tional repression (Sullivan et al., 2001). Using these constructs we
found that gem and zic2 were strongly induced in the NE and ventral
epidermis in nearly every embryo by foxD5VP16, whereas only a few
induced cells were observed after EnRfoxD5 injection in signiﬁcantly
fewer embryos (Figs. 6A, B). zic1, zic3, and Xiro1–3 were strongly
repressed at high frequencies by EnRfoxD5 (Figs. 6A, C). Thus, foxD5
appears to act transcriptionally as both an activator and a repressor.
The effects of these constructs on the sox genes, however, did
not clearly replicate the wt foxD5 phenotypes (Fig. 6A). sox2 wasexpressed high levels of gem, sox11 or zic2 (arrows), indicating that protein synthesis is
nuclei). Dex treatment alone (−Chx/+Dex) induced each gene (arrows) either above
ains of gene expression (⁎, sox11, zic2). The frequencies of the phenotypes and sample
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and soxD was more weakly reduced by both constructs. sox3 was
reduced only by foxD5VP16. sox11 was weakly reduced at gastrula-
tion stages by foxD5VP16, matching the wt foxD5 phenotype, but
was strongly repressed by EnRfoxD5 and neither construct caused its
up-regulation in the neural plate. These results indicate that the
regulation of sox gene expression by wt FoxD5 involves not only
speciﬁc DNA binding via the Forkhead domain included in the
fusion constructs, but also activities mediated by other domains in
the protein (e.g., acidic blob, P/A/Q-rich region, region II, Groucho-
interactive motif) that are not included in the fusion constructs.
These domains may interact with transcriptional co-factors orFig. 8. In combination, gem, sox11 and zic2 account for the foxD5 effects. (A) The percentage
axis) expression after injection of wt foxD5, n-gem, sox11 or zic2 (analyzed at st10–11). Sam
showing the st14 foxD5-MOs phenotype (cf. Fig. 2) after injection of foxD5-MOs alone or in
(i.e., rescue of the phenotype) compared to foxD5-MOs alone (pb0.05, Chi-squared test). S
induced midline expression (arrows) of both sox11 and zic2 in the st13 neural plate (dorsa
expression domains; the sox11 sample was developed only until the induced expression was
foxD5-MOs reduction in zic2 on the injected side (arrow, anterior view at st12, dorsal to the t
Fig. 2E.provide 3-dimensional structure to the protein that is required for
its normal interaction with sox gene regulatory sequences. In
summary, these data demonstrate that FoxD5 functions via multiple
mechanisms (i. e, transcriptional activation, transcriptional repres-
sion, and non-DNA-binding domain interactions) to affect NE gene
expression.
gem, sox11 and zic2 together mediate the foxD5 effects on the other
NE genes
These results do not indicate whether wt foxD5 or the fusion
constructs act directly on the regulatory regions of the NE genes. An inof embryos in which NE genes showed increased (above x-axis) or decreased (below x-
ple sizes for n-gem, sox11 and zic2 are above each bar. (B) The percentage of embryos
combination with n-gem, sox11 or zic2 mRNAs. Asterisks denote signiﬁcant differences
ample sizes for rescue experiments are above each bar. (C) Injection of n-gem mRNA
l views, anterior to the bottom). The asterisks on the zic2 sample denote endogenous
detected, so endogenous levels are not visible. (D) Co-expression of n-gem rescues the
op) but does not rescue the effect on sox2 (arrow, dorsal view at st11, anterior to top). cf.
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site of each of the 11 NE genes revealed at least one generic Forkhead
consensus binding site (P. Grant and S.A. Moody, unpublished),
suggesting that the above effects could be mediated directly. To test
this in the whole embryo, we injected foxD5-hGR mRNA into an NE
precursor blastomere, and when embryos reached st8.5 incubated
them in Chx to prevent further protein synthesis. After 30–40 min,
Dex was added to the culture medium to allow the previously
synthesized FoxD5-hGR protein to access the nucleus. This approach is
only possible for the three genes that were affected by foxD5 by Dex
treatment at st9 (gem, sox11, zic2); the other 8 NE genes require the
presence of FoxD5 during blastula stages at which time Chx treatment
prevents further development. As reported in Fig. 5, Dex treatment
without Chx induced expression of each gene (Fig. 7). Importantly,
each also was induced in the presence of Chx after Dex was added to
the medium; they were not induced in the absence of Dex (Fig. 7).
These results indicate that gem, sox11 and zic2 are direct transcrip-
tional targets of FoxD5.
As direct targets, gem, sox11 and/or zic2 would be expected to
mediate at least some of foxD5's effects on the other NE genes. To
test this, each of these three genes was expressed in the NE
precursor blastomere (Fig. 8A). Similar to foxD5, gem induced zic2
(Fig. 8C), and weakly repressed sox11 at gastrula stages but also
induced sox11 at neural plate stages (42.6%, n=53; Fig. 8C). gem
also caused a reduction in the expression of sox2, soxD, zic1, zic3,
Xiro1 and Xiro3, but at low frequencies (Fig. 8A), indicating it does
not account for the full spectrum of foxD5 effects on these genes.
Similar to foxD5, sox11 induced gem and zic2, and reduced Xiro1–3,
but only weakly repressed sox2, soxD, zic1 and zic3 at low
frequencies (Fig. 8A). Similar to foxD5, zic2 induced gem, and
reduced sox2, sox3, soxD, zic1, zic3, and Xiro1–3. It also reduced
sox11 at gastrula stages, but unlike foxD5 and gem it never induced
sox11 at neural plate stages (Fig. 8A). When expressed in the ventral
epidermis, gem induced zic2 (47%, n=83); sox11 induced gem (94%,
n=48), sox2 (45%, n=42), and zic2 (83%, n=53); and zic2 induced
gem (94%, n=63), and soxD (28%, n=60). A summary of these
effects illustrates that no single target gene accounts for the full
range of the foxD5 effects, but together they account for nearly all of
them (Fig. 9).Fig. 9. A summary of the data from Fig. 8 provides a model neural regulatory network.
FoxD5 directly up-regulates gem, sox11 and zic2. mRNA injection studies show that
these three genes regulate each other and differentially affect the expression of the
other 8 NE genes. Solid black arrows and red inhibitory lines indicate the effect was
observed in 40% or greater of embryos, whereas dashed inhibitory lines indicate the
effect was observed in 10–39% of embryos; if observed in b10% of embryos it was not
considered to be an effect. foxD5-MOs rescue studies show that these three genes
rescue one another, and also some of the other NE genes. A purple asterisk indicates that
signiﬁcant rescue occurred (see Fig. 8B). For sox3, although mRNA injection of gem or
sox11 did not phenocopy that of foxD5, both genes signiﬁcantly rescued the loss of
sox3 expression (purple arrows) caused by foxD5-MOs.To determine whether gem, sox11 and/or zic2 are required for the
foxD5 effects, we co-injected foxD5-MOs with mRNA for each gene
(Fig. 8B). gem signiﬁcantly rescued the effect of foxD5-MOs on sox3,
sox11, soxD and zic2 (Fig. 8D); sox11 signiﬁcantly rescued the effect on
gem, sox3, zic2 and Xiro1–3; and zic2 partially rescued the effect on
gem, sox3, sox11, zic3 and Xiro2. Thus, gem, sox11 and zic2 can rescue
foxD5-MO effects on each other and sox3, but only one or two rescue
the effects on soxD, zic3 and Xiro1–3 and none alone can rescue the
effects on sox2 (Fig. 8D) or zic1. Together, these data demonstrate that
gem, sox11 and zic2: 1) are directly regulated by foxD5; 2) coordinately
regulate each other downstream of foxD5, and 3) are all required to
differentially accomplish the full range of the foxD5 effects on the
other 8 NE genes (Fig. 9).
Some NE genes feedback to down-regulate foxD5 expression
To test whether the 11 NE genes have a reciprocal inﬂuence on
foxD5 we injected NE mRNAs into both NE and ventral epidermis
precursor blastomeres (Fig. 10). n-gem did not alter foxD5 expression
in the NE. sox11, zic1 and zic2 weakly repressed foxD5 in only a small
number of cases. Furthermore, none of these TFs induced ectopic
foxD5 in the epidermis. These results corroborate the above experi-
ments that these genes act downstream of foxD5 (Fig. 9). The
remaining NE genes caused a down-regulation of endogenous foxD5
expression. sox2 and sox3 weakly repressed foxD5 in most embryos,
and zic3, soxD and Xiro1–3 strongly repressed foxD5 in the majority of
cases (Fig. 10). Interestingly, zic3, soxD, Xiro1 and Xiro3 each strongly
repressed foxD5 expression at both early (st10.5) and late (st12)
gastrulation, whereas Xiro2-mediated strong repression was only
detected at late gastrulation. Furthermore, only sox3, which can
down-regulate BMP target genes (Rogers et al., 2008), and Xiro3,
which can induce several early neural markers (Bellefroid et al., 1998),
caused ectopic expression of foxD5 in the epidermis (Fig. 10 insets),
corroborating the placement of foxD5 upstream of this subset of NE
genes. These data indicate that a subset of NE genes feedback to down-
regulate foxD5 in the neural plate. These effects are consistent with
the observations that: 1) foxD5 normally is down-regulated during
neurulation when the process of neural differentiation begins,
whereas the sox, zic and Xiro genes continue to be expressed
throughout neural tube stages (Fig. 1C); and 2) as foxD5 expression
becomes restricted to the medial region of the neural plate, sox gene
expression becomes excluded from the midline and zic and Xiro genes
become restricted to the lateral neural plate (Fig. 1B). Because the
effects appear to be cell-autonomous, we postulate that a mutual
repression between foxD5 and a subset of NE genes likely contributes
to the medial–lateral patterning of the neural plate.
Discussion
A number of TFs are expressed in the vertebrate NE in response to
neural inductive signaling, but their roles in stabilizing neural fate,
expanding the NE, patterning the neural plate and initiating neural
differentiation have not been studied in detail. Understanding how
these TFs relate to each other is fundamental for understanding the
molecular regulation of the progression from the initially-induced NE
to speciﬁed/committed neural stem and progenitor cells that are
poised to begin their various neuronal and glial differentiation
programs. Developmental events often are controlled by gene
regulatory networks of TFs that control temporal and region-speciﬁc
gene expression (Levine and Davidson 2005). Our studies demon-
strate that foxD5 acts upstream of several TFs expressed in the NE that
together: 1) stabilize and expand the NE; 2) pattern the nascent
neural plate; and 3) regulate the onset of neural differentiation. These
are particularly signiﬁcant ﬁndings because although there are
homologous genes in mouse (FoxD4/Fkh2; Kaestner et al., 1995) and
human (FOXD5 [2q13]; Katoh and Katoh, 2004), no functional
Fig. 10. Effects of NE genes on foxD5 expression at gastrulation (st10.5 unless otherwise noted). (A) Cells (red nuclei) expressing n-gem do not alter foxD5 expression (blue); black
arrow points to blastopore lip. Cells expressing (B) sox11 or (F) zic2 showweak repression of foxD5 (clear area surrounding red nuclei noted by small red arrows) in a low percentage
of embryos; cells expressing zic1 usually do not show altered foxD5 expression (E), but in a few cases (12%) there were phenotypes similar to that shown for zic2 (F). Cells expressing
(C) sox2 or (D) sox3 show weak repression of foxD5 (small red arrows) in a majority of embryos. Cells expressing (G) zic3, (H) soxD, (I) Xiro1 or (L) Xiro3 show strong repression of
foxD5 (clear area surrounding red nuclei). Cells expressing Xiro2 rarely showed repression at stage 10.5 (J) but repression is strong by stage 12 (K). Only sox3 and Xiro3 induce ectopic
foxD5 expression (arrows) in the ventral epidermis (inserts, blue cytoplasm surrounding the red nuclei). The frequencies of the phenotypes and sample sizes are indicated in each
panel.
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foxD5 plays a critical upstream role in regulating the NE genes
Each of the NE genes studied herein is induced by inhibition of
BMP signaling alone or in combination with Wnt, Nodal or FGF
signaling at the onset of gastrulation. The zygotic transcription of
these genes in the NE may be independently initiated by these
common signaling pathways, or they may be sequentially activated in
a transcriptional pathway(s). To begin to sort out the relationships
between these TFs, we tested the position of foxD5 in the group by
loss-of-function (LOF) and gain-of-function (GOF) assays. LOF assays
show that foxD5 is required for the NE expression of sox2, sox11, soxD,
zic1 and zic3 at the onset of gastrulation, and for gem, sox3, and zic2
beginning at late gastrulation. These data indicate that the ﬁrst group
either is directly transcribed by FoxD5 (as we show for sox11), or is
dependent on foxD5's ability to locally reduce BMP signaling (see next
section). We posit that the second group is similarly affected, but the
effect is delayed because their maternal mRNAs have not yet been
degraded. Alternatively, these genes may only require foxD5 for the
maintenance of their expression in the neural plate. LOF assay also
show that the requirement for foxD5 by the Xiro genes gradually
increases as the NE matures, suggesting that Xiro genes are activated
by other factors but require foxD5 for their maintenance. Because
increasing foxD5, gem, sox11 and zic2 repress the Xiro genes, we
propose that their maintenance may be provided by the other NE
genes that require foxD5 at the onset of gastrulation (e.g., sox2, soxD,
zic1, zic3). The observation that zic1 and zic3 neural plate domains
expand in the absence of foxD5 indicates that while the loss of foxD5
delays the onset of their expression, other factors can later initiate
them. Together, the LOF assays indicate that while foxD5 is a critical
upstream factor for each of the 11 NE genes, it is not the only factor
required for the onset of their expression in the NE.Assays that increase foxD5 show that this gene alters the
expression of all 11 NE genes; some are induced, some are expanded
and some are repressed. Conversely, none of the 11 NE genes up-
regulates foxD5 expression in the NE. These data indicate that foxD5
functions in an upstream position in the NE. Because the effects on the
NE genes were predominantly cell-autonomous, either FoxD5 directly
interacts with these genes, as the Chx experiments indicate for gem,
sox11 and zic2, or very local signaling is involved. The observations
that foxD5 is required for the expression of NE genes that are reduced
by foxD5 GOF (zic1, zic3, soxD, Xiro1–3) suggest that these genes are
indirectly regulated by FoxD5. This is consistent with our transcrip-
tional network model (Fig. 9), but now requires experimental proof.
Multiple NE genes stabilize neural fate and expand the neural ectoderm
Previous studies indicate that many NE genes do not directly
induce embryonic cells to adopt a neural fate but they are required to
stabilize/maintain that fate and to expand the NE (reviewed in Sasai,
1998; Moody and Je, 2002). For example, zic1 causes the NE to be
more sensitive to neural induction by Noggin (Kuo et al., 1998), sox11
induces neural markers by antagonizing Wnt signaling (Hyodo-Miura
et al., 2002), and gem, sox3 and Xiro1 each antagonize some aspect of
the BMP4 pathway (Kroll et al., 1998; Glavic et al., 2001; Gomez-
Skarmeta et al., 2001; Rogers et al., 2008). Hereinwe show that FoxD5
also represses BMP signaling; it reduces the number of phosphory-
lated SMAD1/5/8-positive cells in the epidermis and reduces the
expression of two ventral epidermal genes that normally are up-
regulated by BMP4 signaling. These effects could be mediated by a
direct repression of bmp transcription or by up-regulating the other
NE genes that reduce BMP signaling. For example, gem expression is
up-regulated by increased foxD5 and down-regulated by reduced
foxD5; sox3 and Xiro1 also are down-regulated by reduced foxD5.
Alternatively, the effects could be mediated by up-regulation of
secreted signaling factors that antagonize components of the BMP
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tion that the expansion of the neural plate caused by increased foxD5
occurs in a non-cell-autonomous fashion, and 2) the up-regulation of
szl, a secreted factor that inhibits tolloid proteinases which in turn
degrade Chordin (Lee et al., 2006). Therefore, it is likely that neural-
fate stabilization and neural plate expansion involve multiple levels of
regulation of the BMP pathway. It will be important to precisely deﬁne
which of the above potential roles of foxD5 are required for this initial
step in neural development.
Some NE genes feedback to down-regulate foxD5 to pattern the neural
plate
None of the 11 NE genes induces foxD5 expression, indicating that
they act downstream. However, a subset (sox2, sox3) weakly and
another strongly (zic3, soxD, Xiro1–3) represses foxD5, suggesting
that they are involved in a negative feedback loop that causes the loss
of foxD5 expression in the neural plate as it matures. This loss may
release the neural plate cells from their immature state and thereby
allow neural differentiation to begin (see next section). In addition,
the locations of the gene expression domains (Fig. 1B) in the neural
plate suggest that the negative feedback also contributes to
regionalizing medial–lateral domains. foxD5 expression becomes
conﬁned to the midline and central anterior regions, whereas the
other NE genes are expressed in more lateral domains. The effects are
cell-autonomous in nature, suggesting that these genes may be directly
regulating foxD5, but this needs to be conﬁrmed experimentally.
A regulatory network controls the transition from immature NE to
neural differentiation
Based on the data presented herein, we propose a regulatory
network inwhich FoxD5 acts upstreamof the other 11 TFs to control the
onset of neural differentiation and thereby promote the maintenance of
an immature neural state (Fig. 9). Previous work showed that: 1) foxD5
expands a marker of immature NE (otx2) and represses neural
patterning (en2, Krox20) and neural differentiation (ngn1, neuroD, n-
tub) genes (Sullivan et al., 2001); 2) gem blocks neural differentiation
genes by regulating SWI/SNF chromatin-remodeling proteins, main-
tains cells in the cell cycle and is down-regulated as neural stem cells
differentiate (Luo et al., 2004; Pitulescu et al., 2005; Seo et al., 2005; Seo
and Kroll 2006; Kroll, 2007; Spella et al., 2007); and 3) zic2 represses
bHLH neural differentiation genes (Brewster et al., 1998). Herein we
show that: 1) foxD5 directly activates gem, sox11 and zic2; 2) its GOF
effects on gem, sox11 and zic2 do not require the expression of the other
NE genes; 3) gem, sox11 and zic2 in combination carry out most of the
effects of foxD5 on the other NE genes; and 4) gem, sox11 and zic2
regulate each other's expression. These observations indicate that foxD5,
gem, sox11 and zic2 form a network rather than a linear path of
transcriptional regulation (Fig. 9). To fully understand the gene
interactions that comprise this network, it will be important to
determinewhether gem, sox11 and zic2 are required for foxD5 expression
and what other genes also take part in the network. It should be noted
that this early role for sox11 has not previously been reported.
Other NE genes are involved in the transition from immature
neural stem to more restricted neural progenitor cells. sox2 and sox3
are necessary for neural differentiation (Kishi et al., 2000;Wegner and
Stolt, 2005; Wang et al., 2006). Each maintains neural stem/
progenitor cells in a proliferative state upstream of neuronal terminal
differentiation genes (Li et al., 1998; Zappone et al., 2000; Bylund et
al., 2003; Graham et al., 2003; Ellis et al., 2004; Bani-Yaghoub et al.,
2006; Wang et al., 2006). Likewise, sox11 is reported to be up-
regulated as neural stem cells transition to neural progenitor cells, and
later it maintains pan-neural genes in neuronal progenitors down-
stream of bHLH differentiation factors (Uwanogho et al., 1995;
Bergsland et al., 2006). Thus, together these sox genes may functiondownstream of foxD5, gem and zic2 to promote the initial step from
neural stem to neural progenitor cell. Our experiments indicate that
foxD5 initially weakly represses sox2, sox3 and sox11, perhaps to
delay this transition. By early neural plate, however, sox2 and sox3 are
no longer reduced and sox11 is up-regulated by direct transcriptional
activation. Thus, foxD5 is required for the stem-to-progenitor transi-
tion. Based on mRNA injections, the foxD5 effects on sox2 and sox3 are
likely mediated primarily by zic2, but foxD5-MO rescue studies show
that gem and sox11 also contribute to sox3 expression (Figs. 8 and 9).
Interestingly, in chick Gem interacts in a complex at the N2 enhancer
to promote sox2 transcription (Papanayotou et al., 2008). However,
we found that gem neither ectopically induced sox2 expression nor
rescued the foxD5-MO reduction of sox2, and Rogers et al. (2009)
showed that sox2 and sox3 directly regulate gem expression. Clearly,
there are multiple levels at which these NE genes can interact.
Finally, several NE genes are involved in moving from a transition
state to the onset of neural differentiation. soxD, zic1, zic3, and Xiro1–3
also expand theNEwhen over-expressed, but they additionally promote
neural progenitor cells and the initiation of neural differentiation gene
expression (Bellefroid et al., 1998; Mizuseki et al., 1998b; Nakata et al.,
1998; Aruga et al., 2002; De la Calle-Mustienes et al., 2002; Inoue et al.,
2007). Previous work showed that foxD5 reduced the expression of
neural differentiation genes, suggesting that one of its functions is to
delay the onset of differentiation (Sullivan et al., 2001). Herein we
conﬁrm this conclusion by showing that foxD5 reduces the expression of
all of the neural differentiation-promoting TFs.
For all six NE genes associated with neural differentiation, FoxD5
activity is required prior to the onset of gastrulation to mimic the full
effect of wt foxD5 mRNA injections. We do not know whether the
activity of maternal foxD5, early transcription of foxD5 at blastula
stages or the input of other genes contributes to the foxD5 effects on
these six NE genes. For example, the expansion of zic1 and zic3 in the
absence of FoxD5 indicates that they are positively regulated by other
factors. We also do not know if the repression of these six NE genes is
direct. While this is suggested by the cell-autonomous nature of the
effects, our data also show that intermediate genes could be
responsible; zic2 represses all of them and gem and sox11 both
contribute to their reduction. Because each gene contains a Forkhead
binding consensus site, further studies are needed to determine if
FoxD5 also binds directly to their regulatory regions.
In conclusion, elucidating the molecules and interactions that
comprise the regulatory network that stabilizes and expands the NE,
patterns the neural plate and controls the onset of neural differentia-
tion is critical information for understanding how the vertebrate CNS
forms. Although a large number of transcription factors have been
identiﬁed that are expressed during these early developmental
stages, there have been very few experiments that relate these
genes to each other or deﬁne their functions in the NE. We
demonstrate that foxD5 is a critical element in this regulatory
network. It acts directly via gem, sox11 and zic2 to differentially
regulate several downstream genes, the effect of which is to hold the
NE in an immature state and to prevent the onset of neural
differentiation. Further elucidation of how these different NE genes
interact to regulate neural speciﬁcation and differentiation should
ultimately prove useful for regulating the expansion and differentiation
of neural stem and progenitor cells.
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